Literature DB >> 9742507

High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells.

S Todoroki1, S Goto, Y Urata, K Komatsu, K Sumikawa, T Ogura, I Matsuda, T Kondo.   

Abstract

Hereditary argininemia manifests as neurological disturbance and mental retardation, features not observed in other amino acidemias. The cytotoxic effect of a high concentration of L-arginine (L-Arg) was investigated using NB9 human neuroblastoma cells (NB9), which express neuronal nitric oxide synthase (nNOS). When the concentration of L-Arg in the medium increased from 50 microM to 2 mM after incubation for 48 hr, the intracellular concentration of L-Arg increased from 68.0 +/- 1 pmol/10(6) cells to 1310.0 +/- 5 pmol/10(6) cells and that of L-citrulline (L-Cit) from undetectable levels to 47.1 +/- 0.2 pmol/10(6) cells (mean +/- SD of three independent analyses). This increase in intracellular L-Arg levels caused a decrease in NOS activity by approximately 71%. Flow cytometric analysis showed that reactive oxygen species (ROS) are produced in NB9 exposed to 2 mM L-Arg. The production of ROS was abolished by a NOS inhibitor, NG-nitro-L arginine-methylester. Production of ROS was also observed when NB9 were treated with L-Cit for 48 hr. To investigate the effect of L-Cit on the activity of NOS, a kinetic study on nNOS was conducted using cellular extracts from NB9. The apparent Km value of nNOS for L-Arg was 8.4 microM, with a Vmax value of 8.2 pmol/min/mg protein. L-Cit competitively inhibited NOS activity, as indicated by an apparent Ki value of 65 nM. These results suggest that L-Cit formed by nNOS in L-Arg-loaded neuronal cells inhibits NOS activity and nNOS in these L-Arg-loaded cells functions as a NADPH oxidase to produce ROS, which may cause neurotoxicity in argininemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742507      PMCID: PMC2230401     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  28 in total

1.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

2.  The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system.

Authors:  J A Gally; P R Montague; G N Reeke; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23.

Authors:  R S Sparkes; G J Dizikes; I Klisak; W W Grody; T Mohandas; C Heinzmann; S Zollman; A J Lusis; S D Cederbaum
Journal:  Am J Hum Genet       Date:  1986-08       Impact factor: 11.025

4.  Molecular cloning and nucleotide sequence of cDNA for human liver arginase.

Authors:  Y Haraguchi; M Takiguchi; Y Amaya; S Kawamoto; I Matsuda; M Mori
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.

Authors:  B Marescau; P P De Deyn; A Lowenthal; I A Qureshi; I Antonozzi; C Bachmann; S D Cederbaum; R Cerone; N Chamoles; J P Colombo
Journal:  Pediatr Res       Date:  1990-03       Impact factor: 3.756

6.  Localization of nitric oxide synthase indicating a neural role for nitric oxide.

Authors:  D S Bredt; P M Hwang; S H Snyder
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

7.  Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells.

Authors:  M Iwanaga; K Mori; T Iida; Y Urata; T Matsuo; A Yasunaga; S Shibata; T Kondo
Journal:  Free Radic Biol Med       Date:  1998-05       Impact factor: 7.376

8.  Molecular basis of argininemia. Identification of two discrete frame-shift deletions in the liver-type arginase gene.

Authors:  Y Haraguchi; J M Aparicio; M Takiguchi; I Akaboshi; M Yoshino; M Mori; I Matsuda
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

9.  Human liver-type arginase gene: structure of the gene and analysis of the promoter region.

Authors:  M Takiguchi; Y Haraguchi; M Mori
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

10.  Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.

Authors:  D A Bass; J W Parce; L R Dechatelet; P Szejda; M C Seeds; M Thomas
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  3 in total

1.  Intracerebroventricular Administration of L-arginine Improves Spatial Memory Acquisition in Triple Transgenic Mice Via Reduction of Oxidative Stress and Apoptosis.

Authors:  Gennadiy Fonar; Baruh Polis; Tomer Meirson; Alexander Maltsev; Evan Elliott; Abraham O Samson
Journal:  Transl Neurosci       Date:  2018-05-31       Impact factor: 1.757

2.  Citrulline Improves Early Post-Ischemic Recovery or Rat Hearts In Vitro by Shifting Arginine Metabolism From Polyamine to Nitric Oxide Formation.

Authors:  Marc Heidorn; Tim Frodermann; Andreas Böning; Rolf Schreckenberg; Klaus-Dieter Schlüter
Journal:  Clin Med Insights Cardiol       Date:  2018-04-24

3.  Evaluation of Plasma Amino Acid Levels in Preterm Infants and Their Potential Correlation with Retinopathy of Prematurity.

Authors:  Yasin Ozcan; Gumus Huseyin; Kenan Sonmez
Journal:  J Ophthalmol       Date:  2020-11-10       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.